THE SOCIETY OF UROLOGIC ONCOLOGY

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

Daniel W Lin MD

Phone

8475177225

Tax Period

2024-05-01 to 2025-04-30

THE SOCIETY OF UROLOGIC ONCOLOGY, founded in 1999, is a community nonprofit in the Medical Research sector that reported $3.3M in total revenue in fiscal year 2024. Revenue grew 19% year-over-year, indicating healthy expansion. The organization ran a surplus of $1.1M, a strong 35% operating margin.

Mission

THE SOCIETY OF UROLOGIC ONCOLOGY THE SOCIETY IS A NATIONAL ORGANIZATION WHOSE PURPOSE IS TO IMPROVE THE CARE OF PATIENTS WITH MALIGNANT UROLOGIC DISEASE BY 1 PROVIDING A FORUM FOR THE DISCUSSION OF PROBLEMS RELATING TO MALIGNANT UROLOGIC DISEASE 2 STIMULATING RESEARCH IN, AND THE TEACHING OF, UROLOGIC ONCOLOGY 3 DISSEMINATING THE PRINCIPLES OF UROLOGIC ONCOLOGY TO THE MEDICAL PROFESSION AT LARGE 4 ESTABLISHING TRAINING GUIDELINES AND PROGRAM OVERSIGHT FOR THE DEVELOPMENT OF UROLOGIC ONCOLOGISTS.

Program Service Accomplishments

Program 1

Expenses: $1,539,427 Revenue: $2,896,068

Annual Conference: The Society holds an annual conference each year to convene leading urologic oncologists, medical oncologists, and scientists to discuss state-of-the-art translational topics on...

Annual Conference: The Society holds an annual conference each year to convene leading urologic oncologists, medical oncologists, and scientists to discuss state-of-the-art translational topics on prostate, kidney, and bladder cancer, as well as strategies in urologic oncology.

Program 2

Expenses: $500 Revenue: $1,000

Fellowship: The program provides additional training in Urological Oncology above and beyond residency. This additional training will specifically provide a multidisciplinary exposure to Urological Oncology and provide an opportunity to spend an extended period of time devoted to the care of patients with genitourinary malignancies and urologic oncology research in order to prepare the fellow for a productive career in Urologic Oncology.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $700

Program Service Revenue $2,897,068

Investment Income $345,328

Other Revenue $10,087

TOTAL REVENUE $3,253,183

Expense Breakdown

Grants Paid $60,238

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,539,927

Other Expenses $2,044,350

TOTAL EXPENSES $2,104,588

Year-over-Year Comparison

	2024	2023	Change
Revenue	$3,253,183	$2,737,869	+0.2%
Expenses	$2,104,588	$1,670,097	+0.3%
Net Income	$1,148,595	$1,067,772	+0.1%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Daniel W Lin MD	President	1.00	Officer Director	$0	$0	$0
Adam Stuart Kibel MD	President-Elect	1.00	Officer Director	$0	$0	$0
Kirsten Lynn Greene MD MS	Secretary	1.00	Officer Director	$0	$0	$0
Sam S Chang MD MBA	Treasurer	1.00	Officer Director	$0	$0	$0
Jeffrey Maxwell Holzbeierlein	Past President	1.00	Officer Director	$0	$0	$0
Scott E Eggener MD	Director	1.00	Director	$0	$0	$0
Sima Prabodh Porten MD MPH	Director	1.00	Director	$0	$0	$0
Mark D Tyson MD MPH	Director	1.00	Director	$0	$0	$0
MICHAEL J DROLLER MD	HISTORIAN	1.00	Director	$0	$0	$0
Yaw A Nyame MD MS MBA	Director	1.00	Director	$0	$0	$0
Mary Elizabeth Westerman MD	Director	1.00	Director	$0	$0	$0
Heather Swanson	Executive Dir.	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$3,253,183	$2,104,588	$9,720,874	$1,148,595
2024	$2,737,869	$1,670,097	$8,209,357	$1,067,772
2023	$2,403,779	$1,832,592	$7,256,903	$571,187
2022	$2,308,651	$1,297,200	$6,729,720	$1,011,451
2021	$1,132,993	$562,767	$5,835,722	$570,226
2020	$1,784,776	$1,781,777	$4,686,933	$2,999
2019	$1,478,331	$803,286	$4,957,829	$675,045
2019	$1,478,331	$803,286	$4,957,829	$675,045
2018	$1,502,382	$772,611	$4,238,929	$729,771